Literature DB >> 9871617

Modifications of the 4,4'-residues and SAR studies of Biphalin, a highly potent opioid receptor active peptide.

G Li1, W Haq, L Xiang, B S Lou, R Hughes, I A De Leon, P Davis, T J Gillespie, M Romanowski, X Zhu, A Misicka, A W Lipkowski, F Porreca, T P Davis, H I Yamamura, D F O'Brien, V J Hruby.   

Abstract

Modifications of 4,4' residues of Biphalin have resulted in greater binding selectivity and biological potency for the mu opioid receptor. A higher partition coefficient across the phospholipid bilayer membrane has been achieved by using a beta-branched unusual amino acids.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871617     DOI: 10.1016/s0960-894x(98)00065-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  New potent biphalin analogues containing p-fluoro-L-phenylalanine at the 4,4' positions and non-hydrazine linkers.

Authors:  Adriano Mollica; Francesco Pinnen; Federica Feliciani; Azzurra Stefanucci; Gino Lucente; Peg Davis; Frank Porreca; Shou-Wu Ma; Josephine Lai; Victor J Hruby
Journal:  Amino Acids       Date:  2010-10-06       Impact factor: 3.520

2.  Solution-phase-peptide synthesis via the group-assisted purification (GAP) chemistry without using chromatography and recrystallization.

Authors:  Jianbin Wu; Guanghui An; Siqi Lin; Jianbo Xie; Wei Zhou; Hao Sun; Yi Pan; Guigen Li
Journal:  Chem Commun (Camb)       Date:  2014-02-07       Impact factor: 6.222

3.  MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years.

Authors:  N Benton; N Stewart; J Crabbe; E Robinson; S Yeoman; F M McQueen
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

Review 4.  Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?

Authors:  Patrycja Redkiewicz; Jolanta Dyniewicz; Aleksandra Misicka
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.